Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.076448v1, 2007; 10.1373/clinchem.2006.076448
This Article
Right arrow Full Text (PDF)
Right arrow 076448.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.076448v1
53/2/326    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Obeid, R.
Right arrow Articles by Herrmann, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Obeid, R.
Right arrow Articles by Herrmann, W.

Received on July 13, 2006
Accepted on November 17, 2006

General Clinical Chemistry

Biomarkers of Folate and Vitamin B12 Are Related in Blood and Cerebrospinal Fluid

Rima Obeid 1, Panagiotis Kostopoulos 2, Jean-Pierre Knapp 1, Mariz Kasoha 1, George Becker 2, Klaus Fassbender 2, Wolfgang Herrmann 1*

1 Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Saarland, Homburg/Saar, Germany
2 Department of Neurology, Faculty of Medicine, University Hospital of Saarland, Homburg/Saar, Germany

* To whom correspondence should be addressed. E-mail: kchwher{at}uniklinikum-saarland.de.

Background: B-vitamins (folate, B12) are important micronutrients for brain function and essential cofactors for homocysteine (HCY) metabolism. Increased HCY has been related to neurological and psychiatric disorders. We studied the role of the B-vitamins in HCY metabolism in the brain.

Methods: We studied blood and cerebrospinal fluid (CSF) samples from 72 patients who underwent lumbar puncture. We measured HCY, methylmalonic acid (MMA), and cystathionine by gas chromatography-mass spectrometry; S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) by liquid chromatography-tandem mass spectrometry; and the B-vitamins by HPLC or immunoassays.

Results: Concentrations were lower in CSF than serum or plasma for HCY (0.09 vs 9.4 µmol/L), SAH (13.2 vs 16.8 nmol/L), cystathionine (54 vs 329 nmol/L), and holotranscobalamin (16 vs 63 pmol/L), whereas concentrations in CSF were higher for MMA (359 vs 186 nmol/L) and SAM (270 vs 113 nmol/L; all P <0.05). CSF concentrations of HCY correlated significantly with CSF folate (r = -0.46), CSF SAH (r = 0.48), CSF-albumin (r = 0.31), and age (r = 0.32). Aging was also associated with lower concentrations of CSF-folate and higher CSF-SAH. The relationship between serum and CSF folate depended on serum folate: the correlation (r) of serum and CSF-folate was 0.69 at serum folate <15.8 nmol/L. CSF concentrations of MMA and holotranscobalamin were not significantly correlated.

Conclusions: CSF and serum/plasma concentrations of vitamin biomarkers are significantly correlated. Older age is associated with higher CSF-HCY and CSF-SAH and lower CSF-folate. These metabolic alterations may be important indicators of low folate status, hyperhomocysteinemia, and neurodegenerative diseases.




The following articles in journals at HighWire Press have cited this article:


Home page
JAMAHome page
P. S. Aisen, L. S. Schneider, and M. Sano
High-Dose B Vitamin Supplements and Alzheimer Disease--Reply
JAMA, March 11, 2009; 301(10): 1021 - 1022.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Wagner and M. J Koury
S-Adenosylhomocysteine a better indicator of vascular disease than homocysteine?
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1581 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Obeid, M. Kasoha, J.-P. Knapp, P. Kostopoulos, G. Becker, K. Fassbender, and W. Herrmann
Folate and Methylation Status in Relation to Phosphorylated Tau Protein(181P) and {beta}-Amyloid(1-42) in Cerebrospinal Fluid
Clin. Chem., June 1, 2007; 53(6): 1129 - 1136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.